Systematic Financial Management LP increased its stake in shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 1.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 171,272 shares of the pharmacy operator’s stock after buying an additional 2,826 shares during the period. Systematic Financial Management LP’s holdings in Walgreens Boots Alliance were worth $14,261,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Schmidt P J Investment Management Inc. boosted its stake in shares of Walgreens Boots Alliance by 4.2% in the second quarter. Schmidt P J Investment Management Inc. now owns 66,945 shares of the pharmacy operator’s stock valued at $5,575,000 after buying an additional 2,700 shares in the last quarter. Denver Investment Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 3.7% in the second quarter. Denver Investment Advisors LLC now owns 115,191 shares of the pharmacy operator’s stock valued at $9,592,000 after buying an additional 4,112 shares in the last quarter. OLD National Bancorp IN boosted its stake in shares of Walgreens Boots Alliance by 4.1% in the second quarter. OLD National Bancorp IN now owns 46,866 shares of the pharmacy operator’s stock valued at $3,903,000 after buying an additional 1,843 shares in the last quarter. Financial Counselors Inc. boosted its stake in shares of Walgreens Boots Alliance by 0.9% in the second quarter. Financial Counselors Inc. now owns 145,139 shares of the pharmacy operator’s stock valued at $12,086,000 after buying an additional 1,266 shares in the last quarter. Finally, Atlanta Capital Group boosted its stake in shares of Walgreens Boots Alliance by 1.1% in the second quarter. Atlanta Capital Group now owns 4,088 shares of the pharmacy operator’s stock valued at $340,000 after buying an additional 45 shares in the last quarter. 59.74% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded up 1.51% on Thursday, hitting $81.80. 3,074,758 shares of the company’s stock were exchanged. The company has a market cap of $88.53 billion, a PE ratio of 28.27 and a beta of 1.01. Walgreens Boots Alliance Inc. has a 12-month low of $71.50 and a 12-month high of $95.74. The company’s 50-day moving average price is $81.71 and its 200-day moving average price is $81.27.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, July 6th. The pharmacy operator reported $1.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.14 by $0.04. The business had revenue of $29.50 billion for the quarter. Walgreens Boots Alliance had a net margin of 2.70% and a return on equity of 15.56%. Walgreens Boots Alliance’s revenue was up 2.4% on a year-over-year basis. During the same period last year, the firm posted $1.02 earnings per share. Analysts forecast that Walgreens Boots Alliance Inc. will post $4.51 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Monday, September 12th. Investors of record on Friday, August 19th were paid a dividend of $0.375 per share. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.36. This represents a $1.50 annualized dividend and a yield of 1.86%. The ex-dividend date of this dividend was Wednesday, August 17th. Walgreens Boots Alliance’s dividend payout ratio is presently 51.90%.

Several analysts have recently issued reports on WBA shares. Credit Suisse Group AG restated a “buy” rating and set a $82.51 target price (down from $95.00) on shares of Walgreens Boots Alliance in a research report on Monday, July 18th. Bank of America Corp. restated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, June 13th. Deutsche Bank AG restated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Friday, June 10th. Barclays PLC upped their target price on shares of Walgreens Boots Alliance from $76.00 to $79.00 and gave the company an “equal weight” rating in a research report on Thursday, July 7th. Finally, Leerink Swann reissued an “outperform” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Monday. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the stock. Walgreens Boots Alliance presently has a consensus rating of “Buy” and an average target price of $93.13.

In related news, Director William C. Foote sold 2,067 shares of the company’s stock in a transaction that occurred on Tuesday, July 26th. The shares were sold at an average price of $81.35, for a total transaction of $168,150.45. Following the sale, the director now directly owns 26,690 shares of the company’s stock, valued at approximately $2,171,231.50. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Kathleen Wilson-Thompson sold 29,695 shares of the company’s stock in a transaction that occurred on Friday, July 8th. The stock was sold at an average price of $81.03, for a total transaction of $2,406,185.85. The disclosure for this sale can be found here. Corporate insiders own 21.10% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.